preview api weak persist expect recoveri
yuhan like report weak set result
week jan tbc api division weak like continu
weigh earn compani indic export
volum hcv segment continu declin due end-product
sale weak gilead
pharma division product updat track
newli introduc harvoni/sovaldi sale may come
posit surpris base channel check
discontinu littl impact yuhan
continu distribut
despit weaken api busi anticip hiv momentum
build recent disclosur one mid-dec one early-jan
assur hiv order gilead acceler upcom
bic combo approv new hiv product gilead fda end-
jan could anoth boost api division recoveri
revis ep reflect weaker api reflect
recent bonu issu common share tp rise
roll earn
estimate pot chg tp
 chang prev ep
note yuhan corp manufactur market variou pharmaceut product
partnership global pharmaceut compani compani also produc
person care product etc affili
click detail financi
like weak alreadi price
yuhan like report weak set result op bn cse vs
bbg bn week jan tbc api division weak
like continu weigh earn compani indic
export volum hcv segment continu declin due end-
product sale weak gilead
api recoveri driven hiv new product launch
despit weaken api busi anticip hiv momentum build
recent disclosur one mid-dec one early-jan assur hiv
order gilead acceler assum two differ
ingredi upcom bic combo approv new hiv product gilead
fda end-jan anoth boost api division recoveri
compani data bloomberg profession servic cs estim
figur quarterli division forecastsexpect api pick-up
figur gilead sale segmentshcv segment declin trigger
weaker api sale yuhan improv hiv help api recoveri
revis ep reflect weaker
api reflect recent bonu share issu common share
disclos late-dec up tp
roll earn
figur consensu valuationyuhan price-to-earnings hover around
argu up averag
pharma division product updat track
newli introduc harvoni/sovaldi sale may come
posit surpris base channel check
discontinu littl impact yuhan continu
distribut annual sale amount around
bn book
compani data bloomberg profession servic cs estim
seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid
report singl factor make invest decis
hivexist hcv ex-sovaldihcv hiv new product usd bn hcvslowdown off-set new product launch epclusa vosevi bic/f/taf forward consensu p/eavg lack pipelin amid market favor d-driven playersanoth de-rat post earn charl tineau pm univers toronto
compani mention price
ray certifi view express report accur reflect person view subject compani secur
part compens directli indirectli relat specif recommend view express report
price rate histori incorpor gild oq
signifi initi assumpt coverag
price rate histori yuhan corp
signifi initi assumpt coverag
analyst respons prepar research report receiv compens base upon variou factor includ credit suiss total
revenu portion gener credit suiss invest bank activ
decemb analyst stock rate defin follow
outperform stock total return expect outperform relev benchmark next month
neutral stock total return expect line relev benchmark next month
under-perform stock total return expect under-perform relev benchmark next month
relev benchmark region decemb japanes rate base stock total return rel analyst coverag univers
consist compani cover analyst within relev sector outperform repres attract neutral less attract
underperform least attract invest opportun octob canadian well european ra ting base stock total return
rel analyst coverag univers consist compani cover analyst within relev sector outperform repres
attract neutral less attract under-perform least attract invest opportun latin american asia stock exclud japan
australia rate base stock total return rel averag total return relev countri regio nal benchmark india bse sensex index
prior octob canadian rate base stock absolut total return potenti curren share price rel
attract stock total return potenti within analyst cover age univers australian new zealand stock expect total return calcul
includ roll dividend yield outperform rate assign greater equal under-perform wh ere less
equal neutral may assign overlap rate rang allow analyst assign rate put
context associ risk prior may rang outperform underperfor rate overlap neutral threshold
oper juli
restrict certain circumst credit suiss polici and/or applic law regul preclud certain type commun
includ invest recommend cours credit suiss engag invest bank transact certain
rate nr credit suiss equiti research invest rate view stock secur relat compani
time
cover nc credit suiss equiti research provid on-going coverag compani offer invest rate invest view
equiti secur compani relat product
volatil indic stock defin volatil stock price move month least past
month analyst expect signific volatil go forward
analyst sector weight distinct analyst stock rate base analyst expect fundament and/or valuat
sector rel group histor fundament and/or valuat
overweight analyst expect sector fundament and/or valuat favor next month
market weight analyst expect sector fundament and/or valuat neutral next month
underweight analyst expect sector fundament and/or valuat cautiou next month
analyst coverag sector consist compani cover analyst within relev sector analyst may cov er multipl sector
credit suiss distribut stock rate bank client
bank client
purpos nyse finra rate distribut disclosur requir stock rate outperform neutral nd under-perform close correspond
